-
1
-
-
37649015497
-
Meta-analysis of hepatic arterial infusion for unresectable liver metastases from colorectal cancer: The end of an era?
-
Mocellin S, Pilati P, Lise M, et al: Meta-analysis of hepatic arterial infusion for unresectable liver metastases from colorectal cancer: The end of an era? J Clin Oncol 25:5649-5654, 2007
-
(2007)
J Clin Oncol
, vol.25
, pp. 5649-5654
-
-
Mocellin, S.1
Pilati, P.2
Lise, M.3
-
2
-
-
23844448040
-
Neoadjuvant treatment of unresectable colorectal liver metastases: Correlation between tumour response and resection rates
-
Folprecht G, Grothey A, Alberts S, et al: Neoadjuvant treatment of unresectable colorectal liver metastases: Correlation between tumour response and resection rates. Ann Oncol 16:1311-1319, 2005
-
(2005)
Ann Oncol
, vol.16
, pp. 1311-1319
-
-
Folprecht, G.1
Grothey, A.2
Alberts, S.3
-
3
-
-
34347250423
-
Neoadjuvant chemotherapy for patients with liver metastases from colorectal cancer
-
Mandalà M, Mosconi S, Quadri A, et al: Neoadjuvant chemotherapy for patients with liver metastases from colorectal cancer. Expert Rev Anticancer Ther 7:887-897, 2007
-
(2007)
Expert Rev Anticancer Ther
, vol.7
, pp. 887-897
-
-
Mandalà, M.1
Mosconi, S.2
Quadri, A.3
-
4
-
-
24644484863
-
Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer
-
Kemeny N, Jarnagin W, Paty P, et al: Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer. J Clin Oncol 23:4888-4896, 2005
-
(2005)
J Clin Oncol
, vol.23
, pp. 4888-4896
-
-
Kemeny, N.1
Jarnagin, W.2
Paty, P.3
-
5
-
-
35348854952
-
Outcome of posthepatectomy: Missing colorectal liver metastases after complete response to chemotherapy - Impact of adjuvant intra-arterial hepatic oxaliplatin
-
Elias D, Goere D, Boige V, et al: Outcome of posthepatectomy: Missing colorectal liver metastases after complete response to chemotherapy - Impact of adjuvant intra-arterial hepatic oxaliplatin. Ann Surg Oncol 14:3188-3194, 2007
-
(2007)
Ann Surg Oncol
, vol.14
, pp. 3188-3194
-
-
Elias, D.1
Goere, D.2
Boige, V.3
-
6
-
-
35448982148
-
Predictors of a true complete response in colorectal liver metastases that disappear radiographically following chemotherapy
-
suppl; abstr 4058, 178s
-
Taylor RA, White RR, Kemeny N, et al: Predictors of a true complete response in colorectal liver metastases that disappear radiographically following chemotherapy. J Clin Oncol 25:178s 2007 (suppl; abstr 4058)
-
(2007)
J Clin Oncol
, vol.25
-
-
Taylor, R.A.1
White, R.R.2
Kemeny, N.3
-
7
-
-
37349026722
-
Hepatic arterial infusion plus systemic irinotecan in patients with unresectable hepatic metastases from colorectal cancer previously treated with systemic oxaliplatin: A retrospective analysis
-
Gallagher DJ, Capanu M, Raggio G, et al: Hepatic arterial infusion plus systemic irinotecan in patients with unresectable hepatic metastases from colorectal cancer previously treated with systemic oxaliplatin: A retrospective analysis. Ann Oncol 18:1995-1999, 2007
-
(2007)
Ann Oncol
, vol.18
, pp. 1995-1999
-
-
Gallagher, D.J.1
Capanu, M.2
Raggio, G.3
-
8
-
-
84871470333
-
Predictive factors for resection of unresectable metastases from colorectal cancer in patients treated with hepatic arterial infusion (HAI) with floxuridine (FUDR) and dexamethasone (DEX) plus IV oxaliplatin (Oxali) and irinotecan (CPT)
-
Presented at the, January 25-27, Orlando, FL abstr 361
-
Huitzil FD, Capanu M, Paty P, et al: Predictive factors for resection of unresectable metastases from colorectal cancer in patients treated with hepatic arterial infusion (HAI) with floxuridine (FUDR) and dexamethasone (DEX) plus IV oxaliplatin (Oxali) and irinotecan (CPT). Presented at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium, January 25-27, 2008, Orlando, FL (abstr 361)
-
(2008)
American Society of Clinical Oncology Gastrointestinal Cancers Symposium
-
-
Huitzil, F.D.1
Capanu, M.2
Paty, P.3
-
9
-
-
33846938353
-
Combination chemotherapy with hepatic arterial infusion of 5-fluorouracil (5-FU) and systemic irinotecan (CPT-11) in patients with unresectable liver metastases from colorectal cancer [Japanese]
-
Shitara K, Munakata M, Kudo T, et al: Combination chemotherapy with hepatic arterial infusion of 5-fluorouracil (5-FU) and systemic irinotecan (CPT-11) in patients with unresectable liver metastases from colorectal cancer [Japanese]. Gan To Kagaku Ryoho 33:2033-2037, 2006
-
(2006)
Gan To Kagaku Ryoho
, vol.33
, pp. 2033-2037
-
-
Shitara, K.1
Munakata, M.2
Kudo, T.3
-
10
-
-
38049164083
-
Hepatic arterial infusion of oxaliplatin and intravenous LV5FU2 in unresectable liver metastases from colorectal cancer after systemic chemotherapy failure
-
Boige V, Malka D, Elias D, et al: Hepatic arterial infusion of oxaliplatin and intravenous LV5FU2 in unresectable liver metastases from colorectal cancer after systemic chemotherapy failure. Ann Surg Oncol 15:219-226, 2007
-
(2007)
Ann Surg Oncol
, vol.15
, pp. 219-226
-
-
Boige, V.1
Malka, D.2
Elias, D.3
-
11
-
-
24644443860
-
Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: A trial of the gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer
-
Ducreux M, Ychou M, Laplanche A, et al: Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: A trial of the gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer. J Clin Oncol 23:4881-4887, 2005
-
(2005)
J Clin Oncol
, vol.23
, pp. 4881-4887
-
-
Ducreux, M.1
Ychou, M.2
Laplanche, A.3
-
12
-
-
0035873927
-
Phase I study of hepatic arterial infusion of floxuridine and dexamethasone with systemic irinotecan for unresectable hepatic metastases from colorectal cancer
-
Kemeny N, Gonen M, Sullivan D, et al: Phase I study of hepatic arterial infusion of floxuridine and dexamethasone with systemic irinotecan for unresectable hepatic metastases from colorectal cancer. J Clin Oncol 19:2687-2695, 2001
-
(2001)
J Clin Oncol
, vol.19
, pp. 2687-2695
-
-
Kemeny, N.1
Gonen, M.2
Sullivan, D.3
-
13
-
-
3242720345
-
Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer
-
Cunningham D, Humblet Y, Siena S, et al: Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N Engl J Med 351:337-345, 2004
-
(2004)
N Engl J Med
, vol.351
, pp. 337-345
-
-
Cunningham, D.1
Humblet, Y.2
Siena, S.3
-
14
-
-
0033619892
-
Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer
-
Kemeny N, Huang Y, Cohen AM, et al: Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med 341:2039-2048, 1999
-
(1999)
N Engl J Med
, vol.341
, pp. 2039-2048
-
-
Kemeny, N.1
Huang, Y.2
Cohen, A.M.3
-
15
-
-
13744255337
-
Hepatic arterial infusion after liver resection
-
Kemeny NE, Gonen M: Hepatic arterial infusion after liver resection. N Engl J Med 352:734-735, 2005
-
(2005)
N Engl J Med
, vol.352
, pp. 734-735
-
-
Kemeny, N.E.1
Gonen, M.2
-
16
-
-
0141799961
-
Phase I/II study of hepatic arterial therapy with floxuridine and dexamethasone in combination with intravenous irinotecan as adjuvant treatment after resection of hepatic metastases from colorectal cancer
-
Kemeny N, Jarnagin W, Gonen M, et al: Phase I/II study of hepatic arterial therapy with floxuridine and dexamethasone in combination with intravenous irinotecan as adjuvant treatment after resection of hepatic metastases from colorectal cancer. J Clin Oncol 21:3303-3309, 2003
-
(2003)
J Clin Oncol
, vol.21
, pp. 3303-3309
-
-
Kemeny, N.1
Jarnagin, W.2
Gonen, M.3
|